Nizal S. Chandrakumar

Array ( [id] => 5643478 [patent_doc_number] => 20060281933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Processes for the preparation of paclitaxel' [patent_app_type] => utility [patent_app_number] => 11/449075 [patent_app_country] => US [patent_app_date] => 2006-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25603 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281933.pdf [firstpage_image] =>[orig_patent_app_number] => 11449075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5754651 [patent_doc_number] => 20060223800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'PYRAZOLOPYRIDINES AND PYRAZOLOPYRIDAZINES ADN ANTIDIABETICS' [patent_app_type] => utility [patent_app_number] => 11/422338 [patent_app_country] => US [patent_app_date] => 2006-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21447 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223800.pdf [firstpage_image] =>[orig_patent_app_number] => 11422338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5860225 [patent_doc_number] => 20060229458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Processes for the preparation of 2-methylfuran and 2-methyltetrahydrofuran' [patent_app_type] => utility [patent_app_number] => 11/446793 [patent_app_country] => US [patent_app_date] => 2006-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9328 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20060229458.pdf [firstpage_image] =>[orig_patent_app_number] => 11446793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 33220 [patent_doc_number] => 07790894 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-07 [patent_title] => 'Mycobacterial inhibitors' [patent_app_type] => utility [patent_app_number] => 11/422152 [patent_app_country] => US [patent_app_date] => 2006-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12684 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790894.pdf [firstpage_image] =>[orig_patent_app_number] => 11422152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8257866 [patent_doc_number] => 08207345 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'Tetrahydroquinolines for use as modulators of the mitotic motor protein Eg5' [patent_app_type] => utility [patent_app_number] => 11/917309 [patent_app_country] => US [patent_app_date] => 2006-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14904 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11917309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5662164 [patent_doc_number] => 20060252760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Farnesyl transferase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/442758 [patent_app_country] => US [patent_app_date] => 2006-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14323 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252760.pdf [firstpage_image] =>[orig_patent_app_number] => 11442758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7978125 [patent_doc_number] => 08071810 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'C5a receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/915892 [patent_app_country] => US [patent_app_date] => 2006-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 2 [patent_no_of_words] => 41627 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071810.pdf [firstpage_image] =>[orig_patent_app_number] => 11915892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5754691 [patent_doc_number] => 20060223840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Substituted piperidine compounds and methods of their use' [patent_app_type] => utility [patent_app_number] => 11/442075 [patent_app_country] => US [patent_app_date] => 2006-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20914 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223840.pdf [firstpage_image] =>[orig_patent_app_number] => 11442075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5046619 [patent_doc_number] => 20070265293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => '(S)-N-methylnaltrexone' [patent_app_type] => utility [patent_app_number] => 11/441452 [patent_app_country] => US [patent_app_date] => 2006-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 30913 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20070265293.pdf [firstpage_image] =>[orig_patent_app_number] => 11441452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4726717 [patent_doc_number] => 20080206258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Novel Tetrahydropyridothiophenes' [patent_app_type] => utility [patent_app_number] => 11/920572 [patent_app_country] => US [patent_app_date] => 2006-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35447 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206258.pdf [firstpage_image] =>[orig_patent_app_number] => 11920572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 63234 [patent_doc_number] => 07763728 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-27 [patent_title] => 'Tetrahydropyridothiophenes' [patent_app_type] => utility [patent_app_number] => 11/920501 [patent_app_country] => US [patent_app_date] => 2006-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40710 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/763/07763728.pdf [firstpage_image] =>[orig_patent_app_number] => 11920501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5609338 [patent_doc_number] => 20060270854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Crystalline form of a benzimidazole-carboxamide medicinal compound' [patent_app_type] => utility [patent_app_number] => 11/439669 [patent_app_country] => US [patent_app_date] => 2006-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15215 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20060270854.pdf [firstpage_image] =>[orig_patent_app_number] => 11439669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5625970 [patent_doc_number] => 20060264475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'COMPOUNDS, COMPOSITIONS AND METHODS FOR INHIBITING OR TREATING HIV-1' [patent_app_type] => utility [patent_app_number] => 11/419867 [patent_app_country] => US [patent_app_date] => 2006-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5537 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264475.pdf [firstpage_image] =>[orig_patent_app_number] => 11419867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7515556 [patent_doc_number] => 08039628 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Process for preparing (alpha S, beta R)-6-bromo-alpha-[2-(dimethylamino) ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol' [patent_app_type] => utility [patent_app_number] => 11/915204 [patent_app_country] => US [patent_app_date] => 2006-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9499 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039628.pdf [firstpage_image] =>[orig_patent_app_number] => 11915204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4442930 [patent_doc_number] => 07928232 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Method for producing asymmetric tetrasubstituted carbon atom-containing compound' [patent_app_type] => utility [patent_app_number] => 11/914952 [patent_app_country] => US [patent_app_date] => 2006-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16846 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/928/07928232.pdf [firstpage_image] =>[orig_patent_app_number] => 11914952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4634707 [patent_doc_number] => 08013159 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-06 [patent_title] => 'Quinoline derivatives as EP4 antagonists' [patent_app_type] => utility [patent_app_number] => 11/920275 [patent_app_country] => US [patent_app_date] => 2006-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15365 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/013/08013159.pdf [firstpage_image] =>[orig_patent_app_number] => 11920275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 232963 [patent_doc_number] => 07598390 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-06 [patent_title] => 'Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use' [patent_app_type] => utility [patent_app_number] => 11/432814 [patent_app_country] => US [patent_app_date] => 2006-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15174 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/598/07598390.pdf [firstpage_image] =>[orig_patent_app_number] => 11432814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 469371 [patent_doc_number] => 07232916 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-06-19 [patent_title] => 'Process for the preparation of a taxane derivative' [patent_app_type] => utility [patent_app_number] => 11/432866 [patent_app_country] => US [patent_app_date] => 2006-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2827 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/232/07232916.pdf [firstpage_image] =>[orig_patent_app_number] => 11432866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436517 [patent_doc_number] => 20090171104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'PROCESS FOR THE PREPARATION OF ORLISTAT' [patent_app_type] => utility [patent_app_number] => 12/089245 [patent_app_country] => US [patent_app_date] => 2006-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2162 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20090171104.pdf [firstpage_image] =>[orig_patent_app_number] => 12089245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4955647 [patent_doc_number] => 20080188671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Method for Producing 2-Formylfuran-4-Boronic Acid by the Metalation of 4-Halofurfural Acetals in the Presence of Suitable Boronic Acid Esters or Anhydrides' [patent_app_type] => utility [patent_app_number] => 11/912157 [patent_app_country] => US [patent_app_date] => 2006-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3103 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20080188671.pdf [firstpage_image] =>[orig_patent_app_number] => 11912157 [rel_patent_id] =>[rel_patent_doc_number] =>)